Braveheart, Attovia join next wave of biotech IPOs

AI Summary

Biotech startups Braveheart and Attovia plan to launch IPOs, marking the third and fourth offerings this month in a wave of momentum in the biotech sector. These companies aim to capitalize on growing investor interest and recent successful IPOs.

The two startups are the third and fourth, respectively, to outline offerings this month and aim to capitalize on momentum that’s already yielded several big-ticket IPOs.